Which major pharmaceutical company rebranded in 2019 with a new DNA-inspired double helix logo to reflect its shift toward precision medicine and genomics research?

In the competitive medical industry, brand recognition can significantly impact patient trust and market positioning. Healthcare companies often invest millions in logo redesigns to modernize their image or reflect expanded services. This poll tests your knowledge of a major pharmaceutical company's strategic rebranding that sparked industry conversation. How well do you know the visual evolution of medical industry giants?

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Pfizer redesigned its oval blue logo to incorporate a DNA double helix within the 'P'
GlaxoSmithKline (GSK) updated its orange logo to a vibrant orange and purple double helix design
Bayer replaced its cross logo with a stylized double helix in green and blue tones
Johnson & Johnson added a DNA strand to its script logo to emphasize genetic research